109 related articles for article (PubMed ID: 16038031)
41. COX2 inhibitor NS398 reduces HT-29 cell invasiveness by modulating signaling pathways mediated by EGFR and HIF1-α.
Bocca C; Bozzo F; Miglietta A
Anticancer Res; 2014 Apr; 34(4):1793-800. PubMed ID: 24692712
[TBL] [Abstract][Full Text] [Related]
42. Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines.
Parker J; Kaplon MK; Alvarez CJ; Krishnaswamy G
Exp Cell Res; 1997 Oct; 236(1):321-9. PubMed ID: 9344613
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of cyclooxygenase-2 by NS398 attenuates noise-induced hearing loss in mice.
Sun Y; Yu J; Lin X; Tang W
Sci Rep; 2016 Mar; 6():22573. PubMed ID: 26934825
[TBL] [Abstract][Full Text] [Related]
44. [Screening of differentially expressed genes related to laterally spreading tumor by cDNA microarray].
Wang XY; Jiang B; Lai ZS; Ma WM; Geng Y
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1023-5. PubMed ID: 15447852
[TBL] [Abstract][Full Text] [Related]
45. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells.
Narayanan BA; Narayanan NK; Simi B; Reddy BS
Cancer Res; 2003 Mar; 63(5):972-9. PubMed ID: 12615711
[TBL] [Abstract][Full Text] [Related]
46. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
47. [Expression of hexokinase-II gene in human colon cancer cells and the therapeutic significance of inhibition thereof].
Peng QP; Liang HJ; Zhou Q; Zhou JM; Fu XL; Zhong DP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1058-62. PubMed ID: 17672972
[TBL] [Abstract][Full Text] [Related]
48. COX-2 inhibitors suppress integrin alpha5 expression in human lung carcinoma cells through activation of Erk: involvement of Sp1 and AP-1 sites.
Han S; Roman J
Int J Cancer; 2005 Sep; 116(4):536-46. PubMed ID: 15825163
[TBL] [Abstract][Full Text] [Related]
49. NS-398 promotes pancreatic cancer cell invasion by CD147 and MMP-2 via the activation of P38.
Liu H; Xu XF; Zhao Y; Tang MC; Zhou YQ; Gao FH
Mol Med Rep; 2016 Mar; 13(3):2208-14. PubMed ID: 26782265
[TBL] [Abstract][Full Text] [Related]
50. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
51. Co-treatment with Celecoxib or NS398 Strongly Sensitizes Resistant Cancer Cells to Antimitotic Drugs Independent of P-gp Inhibition.
Lim JS; Park Y; Lee BM; Kim HS; Yoon S
Anticancer Res; 2016 Oct; 36(10):5063-5070. PubMed ID: 27798865
[TBL] [Abstract][Full Text] [Related]
52. p38α MAPK mediates 17β-estradiol inhibition of MMP-2 and -9 expression and cell migration in human lovo colon cancer cells.
Hsu HH; Liu CJ; Shen CY; Chen YJ; Chen LM; Kuo WH; Lin YM; Chen RJ; Tsai CH; Tsai FJ; Huang CY
J Cell Physiol; 2012 Nov; 227(11):3648-60. PubMed ID: 22377968
[TBL] [Abstract][Full Text] [Related]
53. Diallyl disulfide inhibits the proliferation of HT-29 human colon cancer cells by inducing differentially expressed genes.
Huang YS; Xie N; Su Q; Su J; Huang C; Liao QJ
Mol Med Rep; 2011; 4(3):553-9. PubMed ID: 21468607
[TBL] [Abstract][Full Text] [Related]
54. Effect of NS-398 on colon cancer cells.
Jia XQ; Zhong N; Han LH; Wang JH; Yan M; Meng FL; Zhang SZ
World J Gastroenterol; 2005 Jan; 11(3):353-6. PubMed ID: 15637743
[TBL] [Abstract][Full Text] [Related]
55. [Differences in gene expression profile between high and low metastatic human colorectal cancer cell lines].
Weng DS; Ding YQ; Sun Q
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):256-9. PubMed ID: 15041535
[TBL] [Abstract][Full Text] [Related]
56. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
Liu LT; Chang HC; Chiang LC; Hung WC
Oncogene; 2002 Nov; 21(54):8347-50. PubMed ID: 12447698
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants.
Fu YG; Sung JJ; Wu KC; Wu HP; Yu J; Chan M; Chan VY; Chan KK; Fan DM; Leung WK
Cancer Lett; 2005 Jun; 224(2):243-52. PubMed ID: 15914275
[TBL] [Abstract][Full Text] [Related]
58. Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis.
Zhu JS; Guo H; Song MQ; Chen GQ; Sun Q; Zhang Q
World J Gastroenterol; 2008 Oct; 14(38):5887-92. PubMed ID: 18855989
[TBL] [Abstract][Full Text] [Related]
59. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma.
Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H
Int J Oncol; 2005 Feb; 26(2):353-60. PubMed ID: 15645119
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
